Capromab Pendetide - ProstaScint; Indium-111 labeled prostate tumor monoclonal antibody -- Product Record

Prostate Mab–In 111 radioconj.

    Nomenclature:
      Prostate Mab–In 111 radioconj. [BIO]
      ProstaScint [TR (for Capromab Pendetide immunoconjugate)]
      Indium In 111 ProstaScint [TR (for final radioimmune conjugate)]
      Capromab Pendetide [FDA USAN (for immunoconjugate)]
      Indium In 111 Capromab Pendetide [FDA (for final radioimmune conjugate)]
      Kit for the Preparation of Indium In 111 Capromab Pendetide [FDA (for final radioimmune conjugate preparation kit)]
      Capromab [INN (for monoclonal antibody)]
      Immunoglobulin G 1 (mouse monoclonal 7E11-C5.3 anti-human prostatic carcinoma cell), disulfide with mouse monoclonal 7E11-C5.3 light chain, dimer, N6-(N-[2-[[2-(bis(carboxymethyl)amino]ethyl](-carboxymethyl)-amino)ethyl]-N-(carboxymethyl)glycyl]-N2-(N-glycyl-L-tyrosyl)-L-lysine conjugate [CAS (for immunoconjugate)]
      145464-28-4 [CAS RN (for final radioimmune conjugate)]
      111In-CYT-356 [SY (for monoclonal antibody with linker)]
      7E11-C5 [SY (for monoclonal antibody)]
      7E11-C5.3-GYK-DTPA [SY (for monoclonal antibody with linker)]
      CYT-351 [SY (for monoclonal antibody)]
      CYT-356 [SY (for monoclonal antibody with linker)]
      GYK-DTPA-HCl.CYT-356 [SY (for monoclonal antibody with linker)]
      GYK-DTPA.HCl [SY (for CYT-063 tripeptide linker-chelator)]
      In-111-Capromab Pendetide [SY (for final radioimmune conjugate)]
      CYT-063 [SY (for tripeptide linker-chelator or GYK-DTPA-HCl)]
      glycyl-tyrosyl-(N-epsilon-diethylenetriaminopentaacetic acid)-lysine hydrochoride [SY (for CYT-063 tripeptide linker-chelator)]
      NDC 57902-817-01 [NDC for Capromab Pendetide kit]

    FDA Class:  Biologic BLA

    Year of approval (FDA) = 1996

Index Terms: